Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection
Clinical trial NCT02925416 · COMPLETED
Trial details
- NCT number
- NCT02925416
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-24
- Primary completion
- 2017-06-20
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.